| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.082 | 0.8 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |